<DOC>
	<DOCNO>NCT00001209</DOCNO>
	<brief_summary>This protocol design test feasibility administration vincristine , adriamycin cytoxan , alternate newly develop regimen ifosfamide VP-16 well efficacy therapy addition radiotherapy produce complete response disease-free survival patient Ewing 's sarcoma , primitive sarcoma bone , peripheral neuroepithelioma , soft tissue sarcoma . This randomized study comparable large data base similar patient treat successive Pediatric Branch study .</brief_summary>
	<brief_title>A Pilot Study Treatment Patients With Metastatic High Risk Sarcomas Primitive Neuroectodermal Tumors</brief_title>
	<detailed_description>This protocol design test feasibility administration vincristine , adriamycin cytoxan , alternate newly develop regimen ifosfamide VP-16 well efficacy therapy addition radiotherapy produce complete response disease-free survival patient Ewing 's sarcoma , primitive sarcoma bone , peripheral neuroepithelioma , soft tissue sarcoma . This randomized study comparable large data base similar patient treat successive Pediatric Branch study .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive , Peripheral</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Patients high grade soft tissue sarcoma either metastatic disease stage III tumor include synovial sarcoma , malignant fibrous histiocytoma , hemangiopericytoma , malignant schwannoma ( neurofibrosarcoma ) . Patients must previously treat chemotherapy radiation therapy . The patient age must less equal 25 year . The patient ( guardian 18 year age ) must sign document indicate he/she aware investigational nature treatment protocol potential risk benefit may expect . Patients must direct bilirubin less 4.0 mg/dl . Patients must abnormal cardiac function ( ejection fraction great 45 % MUGA scan confirmation shorteningfraction great 25 % echocardiography ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 1999</verification_date>
	<keyword>Combined Chemotherapy</keyword>
	<keyword>Irradiation</keyword>
	<keyword>Unresectable</keyword>
</DOC>